D'AMBROSIO, ROBERTA

D'AMBROSIO, ROBERTA  

Dipartimento di Fisiopatologia Medico-Chirurgica e dei Trapianti  

Mostra records
Risultati 1 - 20 di 75 (tempo di esecuzione: 0.0 secondi).
Titolo Data di pubblicazione Autori Tipo File Abstract
Is it time to refine HCC surveillance strategies in HCV cured patients? 2022 D'Ambrosio R.Lampertico P. Article (author) -
Clinical exome sequencing for diagnosing severe cryptogenic liver disease in adults: A case series 2022 Pelusi, SerenaRonzoni, LuisaMalvestiti, FrancescoD'Ambrosio, RobertaGiannotta, Juri AlessandroValenti, Luca + Article (author) -
Obesity Modifies the Performance of Fibrosis Biomarkers in Nonalcoholic Fatty Liver Disease 2022 D'Ambrosio, RobertaPelusi, SerenaValenti, Luca + Article (author) -
Clinical and genetic determinants of the fatty liver–coagulation balance interplay in individuals with metabolic dysfunction 2022 Valenti, LucaTripodi, ArmandoLa Mura, VincenzoPelusi, SerenaScalambrino, EricaMalvestiti, FrancescoRonzoni, LuisaD'Ambrosio, RobertaPeyvandi, Flora + Article (author) -
Dysmetabolism, Diabetes and Clinical Outcomes in Patients Cured of Chronic Hepatitis C: A Real-Life Cohort Study 2022 Valenti L.Pelusi S.Aghemo A.Pasulo L.Degasperi E.D'Ambrosio R.Zuccaro V.Giorgini A.Rumi M. G.Spinelli O.Colombo M. C.Menzaghi B.D'Arminio Monforte A.Bonfanti P.Lampertico P. + Article (author) -
Rare ATG7 genetic variants predispose patients to severe fatty liver disease 2022 Baselli, Guido APelusi, SerenaMalvestiti, FrancescoCherubini, AlessandroDongiovanni, PaolaCespiati, AnnalisaD'Ambrosio, RobertaVaira, ValentinaFracanzani, Anna LValenti, Luca Vc + Article (author) -
Editorial: the role for PIVKA-II measurement after HCV elimination by direct-acting antivirals in terms of prediction of hepatocellular carcinoma—authors' reply 2022 Degasperi E.D'Ambrosio R.Lampertico P. Article (author) -
Decompensation in Direct-Acting Antiviral Cured Hepatitis C Virus Compensated Patients With Clinically Significant Portal Hypertension: Too Rare to Warrant Universal Β-Blocker Therapy 2021 Tosetti G.Degasperi E.Farina E.D'Ambrosio R.Soffredini R.Borghi M.La Mura V.Lampertico P. + Article (author) -
A new algorithm shows superior ability to discriminate liver fibrosis stages in chronic hepatitis C 2021 D'Ambrosio, RobertaPerbellini, RiccardoLombardi, AndreaLampertico, Pietro + Article (author) -
High rates of sustained virological response despite premature discontinuation of directly acting antivirals in HCV-infected patients treated in a real-life setting 2021 Lombardi A.Colaneri M.D'Ambrosio R.Degasperi E.Dibenedetto C.Giorgini A.Pasulo L.Spinelli O.Re T.Rumi M.Aghemo A.Lampertico P.Soffredini R.Perbellini R.Gori A.Colpani M.Manini M.Lazzaroni S.De Nicola S.Angelini Zucchetti T.Rossotti R.Colella E.Magnani C.Mena M.Caramma I.Basilico C.Biagiotti S.Mazzone A.Saladino V.Menzaghi B.Rumi M.Fanetti I.Dibenedetto C.Zermiani P.Zuin M.D'Arminio Monforte A.Capretti A.Messina E.Colombo A. E.Bonfanti P.Conforti S.Menozzi F.Gritti S.Giani P. + Article (author) -
The relationship between liver histology and thyroid function tests in patients with nonalcoholic fatty liver disease (NAFLD) 2021 D'Ambrosio R.Campi I.Perbellini R.Stucchi R.Degasperi E.De Silvestri A.Persani L.Fugazzola L.Lampertico P. + Article (author) -
Advanced liver disease outcomes after hepatitis C eradication by human immunodeficiency virus infection in PITER cohort 2020 Monti, MonicaIannone, AndreaD'Ambrosio, RobertaRumi, Maria GraziaFederico, AlessandroZuin, Massimo + Article (author) -
Hepatic fat - genetic risk score predicts hepatocellular carcinoma in HCV cirrhotic patients treated with DAAs 2020 Degasperi, ElisabettaGalmozzi, EnricoPelusi, SerenaD'Ambrosio, RobertaSoffredini, RobertaPerbellini, RiccardoFacchetti, FlorianaIavarone, MassimoValenti, LucaLampertico, Pietro + Article (author) -
Undefined/non-malignant hepatic nodules are associated with early occurrence of HCC in DAA-treated patients with HCV-related cirrhosis 2020 Valenti L.D'Ambrosio R.Rumi M.Fracanzani A. L.Biganzoli E.Lampertico P. + Article (author) -
Treatment of non-alcoholic steatosis : Preclinical study of a new nutraceutical multitarget formulation 2020 D'ambrosio R.Lampertico P. + Article (author) -
Combination of CLIF-OF and CCI predicts survival in patients with cirrhosis and COVID-19 2020 Massimo IavaroneRoberta D'AmbrosioPietro Lampertico Article (author) -
Non-invasive stratification of hepatocellular carcinoma risk in non-alcoholic fatty liver using polygenic risk scores 2020 Pelusi, SerenaBaselli, GuidoDongiovanni, PaolaMeroni, MaricaBorroni, VittorioD'Ambrosio, RobertaFracanzani, Anna LudovicaValenti, Luca + Article (author) -
Treatment of 320 genotype 3 cirrhotic patients with 12 weeks Sofosbuvir/Velpatasvir with or without ribavirin: real life experience from Italy 2019 D'Ambrosio, R.Di Marco, V.Fabris, P.Lombardi, A.Zuin, M.Aghemo, A.Rumi, M. G.Spinelli, O.Colli, A.Menzaghi, B.Soffredini, R.Colpani, M.Gori, A.Giorgini, A.Capretti, A.Colombo, A. E.Dibenedetto, C.Lampertico, P. + Article (author) -
Real-world effectiveness and safety of glecaprevir/pibrentasvir in 723 patients with chronic hepatitis C 2019 D'Ambrosio, RobertaPasulo, LuisaGatti, FedericoMenzaghi, BarbaraRumi, Maria GraziaGiorgini, AlessiaSpinelli, OmbrettaSaladino, ValeriaBonfanti, PaoloGori, AndreaLampertico, PietroAghemo, Alessio + Article (author) -
Effectiveness and safety of sofosbuvir-based direct-acting antiviral combinations in HCV-2 and HCV-3 kidney transplant recipients 2019 D'Ambrosio, RobertaFranchina, MariannaMessa, PiergiorgioLampertico, Pietro + Article (author) -